Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - Bosnia and Herzegovina

Bosnia and Herzegovina

In Bosnia and Herzegovina, the Treatment of Cardiovascular Diseases market is estimated to achieve a revenue of US$86.17m in the year 2024.
It is anticipated that the revenue will display a compound annual growth rate (CAGR 2024-2029) of 4.66%, leading to a market volume of US$108.20m by the year 2029.
When compared globally, United States is expected to generate the highest revenue, reaching US$136.00bn in 2024.
Bosnia and Herzegovina is witnessing a growing trend in the adoption of advanced cardiovascular treatment technologies.

Key regions: Germany, France, Japan, Europe, India

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.